Oral Treatments For Breast Cancer And Health Promotion Essay
This paper was prepared on December 04, 2016 for Advances Concepts of Client Care I, 109 taught by Professor Chelsea Cheng, MSN, BSN, RN
A Review of Common Oral Treatments for Breast Cancer:
Improving Patient Safety in Nonocologic Settings
Women with breast cancer seek care from nononcologic providers, their reasons are annual wellness visits, treatment of comorbities, emergency visits, monitoring recurrence of cancer, etc. Nurses play an important role in managing these patients and their associated adverse effects (Fischer-Cartlidge, Dicenso, Buckley, & Villanueva, 2016, p. 28, p.34).
Aromatase inhibitors include anastrozole (Arimidex), exemestrane (Aromasin), and letrozole. These are given after surgery with or without chemotherapy and radiation for 5 to 10 years. Adverse effects related to estrogen deprivation include hot flashes, vaginal dryness, headaches, arthralgias, decreased bone density and hypercholesterolemia. Women taking aromatase inhibitors need to increase their dose if taking St. John’s wort herbal supplement (Fischer-Cartlidge et al., 2016)
Selective Estrogen Receptor Modulators (SERM) such as tamoxifen (Soltamox) and raloxifene (Evista) bind to estrogen receptors. They are used for the treatment of ER/PR-positive breast cancer in both premenopausal and postmenopausal women. Adverse effects are…